Study Assessing the Efficacy and Safety of Octreotide Acetate in Patients With Acromegaly, With Micro or Macroadenomas
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of octreotide acetate to decrease GH
and IGF-I levels in acromegalic patients, with microadenomas (≤ 10 mm) or macroadenomas (> 10
mm).